Upgrades
- Morgan Stanley changed the rating for Paychex Inc (NASDAQ:PAYX) from Underweight to Equal-Weight. Paychex earned $0.70 in the second quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $90.53 and a 52-week-low of $54.48. Paychex's stock last closed at $60.79 per share.
- BTIG changed the rating for Globus Medical Inc (NYSE:GMED) from Neutral to Buy. In the fourth quarter, Globus Medical showed an EPS of $0.49, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $60.15 and a 52-week-low of $33.41. Globus Medical's stock last closed at $39.97 per share.
- Susquehanna changed the rating for MGM Resorts International (NYSE:MGM) from Negative to Neutral. In the fourth quarter, MGM Resorts Intl earned $0.08. The stock has a 52-week-high of $34.63 and a 52-week-low of $9.00. MGM Resorts Intl's stock last closed at $9.54 per share.
- B of A Securities changed the rating for Central Garden & Pet Co (NASDAQ:CENT) from Neutral to Buy. In the first quarter, Central Garden & Pet showed an EPS of ($0.08), compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $34.69 and a 52-week-low of $22.40. Central Garden & Pet's stock last closed at $29.65 per share.
- For The Hershey Co (NYSE:HSY), Credit Suisse upgraded the stock from Neutral to Outperform. For the fourth quarter, Hershey had an EPS of $1.28, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $162.20 and a 52-week-low of $108.95. Hershey's stock last closed at $138.94 per share.
- UBS changed the rating for Caterpillar Inc (NYSE:CAT) from Sell to Neutral. For the fourth quarter, Caterpillar had an EPS of $2.63, compared to year-ago quarter EPS of $2.55. The stock has a 52-week-high of $150.55 and a 52-week-low of $87.50. Caterpillar's stock last closed at $100.20 per share.
- Dougherty & Co. changed the rating for NextGen Healthcare Inc (NASDAQ:NXGN) from Neutral to Buy. In the third quarter, NextGen Healthcare showed an EPS of $0.23, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $21.12 and a 52-week-low of $5.10. NextGen Healthcare's stock last closed at $6.15 per share.
- For Change Healthcare Inc (NASDAQ:CHNG), Raymond James upgraded the stock from Outperform to Strong Buy. Interestingly, in the third quarter, Change Healthcare's EPS was $0.33. The stock has a 52-week-high of $17.57 and a 52-week-low of $6.67. Change Healthcare's stock last closed at $7.78 per share.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Downgrades
- Morgan Stanley changed the rating for Monster Beverage Corp (NASDAQ:MNST) from Overweight to Equal-Weight. For the fourth quarter, Monster Beverage had an EPS of $0.47, compared to year-ago quarter EPS of $0.43. The stock has a 52-week-high of $70.52 and a 52-week-low of $52.23. Monster Beverage's stock last closed at $59.74 per share.
- B. Riley FBR downgraded the stock for Sinclair Broadcast Group Inc (NASDAQ:SBGI) from Buy to Neutral. Sinclair Broadcast Group earned $0.94 in the fourth quarter, compared to $2.13 in the year-ago quarter. The stock has a 52-week-high of $66.57 and a 52-week-low of $10.94. Sinclair Broadcast Group's stock last closed at $13.54 per share.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.